Cellular association of antiproteases in lavages from ventilated preterm human neonates

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 6, 1997, Pages 2064-2071

  Griese, Matthias ^a   Schredl, Monika ^a   Hochstrasser, Karl ^a   Gebhard, Wolfgang ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME ASSAY; HUMAN; IMMUNOCYTOCHEMISTRY; INFANT; LUNG DYSPLASIA; LUNG LAVAGE; MACROPHAGE; NEUTROPHIL; PREMATURITY; PRIORITY JOURNAL;

EID: 0030952044     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.6.9196116     Document Type: Article

References (34)

1. Davis, J. M., and W. N. Rosenfeld. 1994. Chronic lung disease. In G. B. Avery, M. A. Fletcher, and M. G. MacDonald, editors. Neonatology: Pathophysiology and Management of the Newborn, 4th ed. Lippincott, Philadelphia.
2. Speer, C. P., D. Ruess, K. Harms, E. Herting, and O. Gefeller. 1993. Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome. Pediatrics 91:794-799.
3. Hochstrasser, K., G. J. Albrecht, Ö. L. Schönberger, B. Rasche, and K. Lempart. 1981. An elastase-specilic inhibitor from human bronchial mucus. Hoppe-Seyler's Z. Physiol. Chem. 362:1369-1375.
4. Klasen, E., C., and J. A. Kramps. 1985. The N-terminal sequence of anti-leukoprotease isolated from bronchial secretion. Biochem. Biophys. Res. Commun. 128:285-289.
5. Boudier, C., D. Carvallo, C. Roitsch, J. G. Bieth, and M. Courtney. 1987. Purification and characterization of human bronchial protease inhibitor. Arch. Biochem. Biophys. 253:439-445.
6. Wiedow, O., J.-M. Schröder, H. Gregory, J. A. Young, and E. Christophers. 1990. Elafin: an elastase-specific inhibitor of human skin. J. Biol. Chem. 265:14791-14795.
7. Sallenave, J., and A. P. Ryle. 1991. Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Hoppe-Seyler's Z. Biol. Chem. 372:13-21.
8. Schalkwijk, J., C de Roo, and G. J. de Jongh. 1991. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes: purification and biochemical properties. Biochem. Biophys. Acta 1096:148-154.
9. Heinzel, R., H. Appelhans, G. Gassen, V. Seemüller, W. Machleidt, H. Fritz, and G. Steffens. 1986. Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. Eur. J. Biochem. 160:61-67.
10. Saheki, T., F. Ito, H. Hagiwara, Y. Saito, J. Kuroki, S. Tachibana, and S. Hirose. 1992. Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment. Biochem. Biophys. Res. Commun. 185:240-245.
11. Merritt, A., C. G. Cochrane, K. Holcomb, B. Bohl, M. Hallman, D. Strayer, D. K. Edwards, and L. Gluck. 1983. Elastase and alphal-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J. Clin. Invest. 72:656-666.
12. Merritt, T. A., M. Hallman, K. Holcomb, D. Strayer, B. Bloom, S. Revak, and C. G. Cochrane. 1986. Human surfactant treatment of severe respiratory distress syndrome: pulmonary effluent indicators of lung inflammation. J. Pediatr. 108:741-748.
13. Walti, H., C. Tordet, L. Gerbaut, P. Saugier, G. Moriette, and J. P. Relier. 1989. Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections. Pediatr. Res. 25:351-355.
14. Ogden, B. E., S. A. Murphy, G. C. Saunders, D. Pathak, and J. D. Johnson. 1984. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am. Rev. Respir. Dis. 130:817-821.
15. Tegtmeyer, F. K., S. Maacks, W. G. Wood, and W. Wiebecke. 1992. Elastase alphal-proteinase inhibitor and lactoferrin concentrations in endotracheal aspirates of ventilated newborns. Pediatr. Pulmonol. 13: 90-94.
16. 2-macroglobulin in serum and lung secretions of intubated infants. Pediatr. Res. 18:35-40.
17. Ohlsson, K., T. Sveger, and N. Svenningsen. 1992. Protease inhibitors in bronchoalveolar lavage fluid from neonates with special reference to secretory leukocyte protease inhibitor. Acta Paediatr. 81:757-759.
18. White, R., A. Janoff, and P. Godfrey. 1980. Secretion of alpha-2-macroglobulin by human alveolar macrophages. Lung 158:9-14.
19. Willems, L. N. A., J. A. Kramps, P. K. Jeffery, and J. H. Dijkman. 1988. Antileucoprotease in the developing fetal lung. Thorax 43:784-786.
20. Watterberg, K. L., D. F. Carmichael, J. S. Gerdes, S. Werner, C. Backstrom, and S. Murphy. 1994. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia. J. Pediatr. 125:264-269.
21. Griese, M., P. Pudenz, R. Feldmann, K. Hochstrasser, and D. Reinhardt. 1993. Free and cell-associated antileukoprotease (ALP) is an inhibitor of human leukocyte elastase in neonatal lung effluent. Eur. J. Pediatr. 152:275 (Abstr. 7).
22. Griese, M., P. Dietrich, and D. Reinhardt. 1995. Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 152:1050-1054.
23. Griese, M., P. Dietrich, C. Potz, B. Westerburg, R. Bals, and D. Reinhardt. 1996. Surfactant subfractions during nosocomial infection in ventilated preterm human neonates. Am. J. Respir. Crit. Care Med. 153:398-403.
24. Ohlsson, K., and I. Olsson. 1974. the neutral protease of human granulocytes. Isolation and partial characterization of'granulocyte elastase. Eur. J. Biochem. 12:519-524.
25. Chase, T., Jr., and E. Shaw. 1967. p-Nitrophenyl-p-guanidinobenzoate HCI: a new site titrant for trypsin. Biochem. Biophys. Res. Commun. 29:508-514.
26. Hochstrasser, K., R. Naumann, and G. J. Albrecht. 1983. Neue Methoden zur differenzierten Erfassung des antiproteolytischen Systems des menschlichen Bronchialsekretes. Atemw. Lungenkrkh. 9:136-139.
27. Chomezynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
28. Van Belkum, A., E. Linkels, T. Jelsma, F. M. van den Berg, and W. Quint. 1994. Non-isotopic labeling of DNA by newly developed hapten-containing platinum compounds. BioTechniques 16:148-153.
29. Neave, C. 1985. Tracheal aspirate cytology in neonatal respiratory distress syndrome and bronchopulmonary dysplasia. In T. A. Merrit, W. H. Northway, and B. R. Boynton, editors. Contemporary Issues in Fetal and Neonatal Medicine: IV. Blackwell Scientific, Oxford, 59-78.
30. Kramps, J. A., C. Franken, C. J. L. M. Meijer, and J. H. Dijkman. 1981. Localization of low molecular weight protease inhibitor in serous secretory cells of the respiratory tract. J. Histochem. Cytochem. 29:712-719.
31. Willems, L. N. A., C. J. M. Otto-Verberne, J. A. Kramps, A. A. W. tenHave-Opbroeck, and J. H. Dijkman. 1986. Detection of antileukoprotease in connective tissue of the lung. Histochemistry 86:165-168.
32. Van-Seuningen, I., M. Davril, and A. Hayem. 1989. Evidence for the tight binding of human mucous proteinase inhibitor to high glycosylated macromolecules in sputum. Hoppe-Seyler's Z. Biol. Chem. 370: 749-755.
33. Remold-O'Donnell, E., J. Chin, and M. Alberts. 1992. Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 89:5635-5639.
34. Sallenave, J. M., G. Cox, M. Chignard, and J. Gaulide. 1994. Secretory leukocyte proteinase inhibitor and elafin: production by neutrophils and stimulation hy proinflammatory mediators (abstract). Am. J. Respir. Crit. Care Med. 149:A869.